Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Zagociguat

Copy Product Info
😃Good
Catalog No. T39673Cas No. 2201048-82-8
Alias IW-6463, IW6463, CY-6463, CY6463

Zagociguat (CY6463) is a soluble guanylate cyclase stimulator with central nervous system penetrance, enhancing nitric oxide (NO) signaling and used in the study of neurological diseases.

Zagociguat

Zagociguat

Copy Product Info
😃Good
Purity: 99.37%
Catalog No. T39673Alias IW-6463, IW6463, CY-6463, CY6463Cas No. 2201048-82-8
Zagociguat (CY6463) is a soluble guanylate cyclase stimulator with central nervous system penetrance, enhancing nitric oxide (NO) signaling and used in the study of neurological diseases.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$100-In Stock
5 mg$247-In Stock
10 mg$396-In Stock
25 mg$787-In Stock
50 mg$1,180-In Stock
100 mg$1,650-In Stock
200 mg$2,220-In Stock
1 mL x 10 mM (in DMSO)$272-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.37%
Appearance:Solid
Color:Yellow
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Zagociguat (CY6463) is a soluble guanylate cyclase stimulator with central nervous system penetrance, enhancing nitric oxide (NO) signaling and used in the study of neurological diseases.
Targets&IC50
CREB:25.7 nM (EC50)
In vitro
CREB phosphorylation was stimulated by Zagociguat in a concentration-dependent manner in primary rat neurons with EC50 of 25.7 nM. [1]
In vivo
When Zagociguat was administered to rats at 10 mg/kg, cGMP levels were higher in cerebrospinal fluid compared to 3 mg/kg, suggesting that Zagociguat is a CNS permeable compound capable of triggering an increase in cGMP in the CNS.
Zagociguat (10 mg/kg) decreased plasma inflammatory markers and increased BDNF in obese mice. [1]
SynonymsIW-6463, IW6463, CY-6463, CY6463
Chemical Properties
Molecular Weight362.28
FormulaC16H10F4N6
Cas No.2201048-82-8
SmilesFC=1C=CC=CC1CC2=NC(=CN3C=CN=C23)C4=NN=C(N4)C(F)(F)F
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 200 mg/mL (552.06 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.7603 mL13.8015 mL27.6030 mL138.0148 mL
5 mM0.5521 mL2.7603 mL5.5206 mL27.6030 mL
10 mM0.2760 mL1.3801 mL2.7603 mL13.8015 mL
20 mM0.1380 mL0.6901 mL1.3801 mL6.9007 mL
50 mM0.0552 mL0.2760 mL0.5521 mL2.7603 mL
100 mM0.0276 mL0.1380 mL0.2760 mL1.3801 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Zagociguat | purchase Zagociguat | Zagociguat cost | order Zagociguat | Zagociguat chemical structure | Zagociguat in vivo | Zagociguat in vitro | Zagociguat formula | Zagociguat molecular weight